Umesh T. Sankpal

1.7k total citations
50 papers, 1.3k citations indexed

About

Umesh T. Sankpal is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Umesh T. Sankpal has authored 50 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 18 papers in Cancer Research and 13 papers in Oncology. Recurrent topics in Umesh T. Sankpal's work include Cancer, Lipids, and Metabolism (8 papers), Inflammatory mediators and NSAID effects (7 papers) and Epigenetics and DNA Methylation (6 papers). Umesh T. Sankpal is often cited by papers focused on Cancer, Lipids, and Metabolism (8 papers), Inflammatory mediators and NSAID effects (7 papers) and Epigenetics and DNA Methylation (6 papers). Umesh T. Sankpal collaborates with scholars based in United States, India and France. Umesh T. Sankpal's co-authors include Riyaz Basha, Keith D. Robertson, Beth O. Van Emburgh, Kevin D. Brown, Stela S. Palii, Maen Abdelrahim, Steven Goodison, Theresa M. Geiman, Nagendra S. Ningaraj and Divya Khaitan and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

Umesh T. Sankpal

49 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Umesh T. Sankpal United States 20 939 201 199 127 123 50 1.3k
Shoshana Paglin United States 14 950 1.0× 224 1.1× 238 1.2× 99 0.8× 90 0.7× 20 1.8k
Yingjie Li China 18 944 1.0× 285 1.4× 212 1.1× 102 0.8× 58 0.5× 55 1.5k
Wei‐En Yang Taiwan 16 713 0.8× 391 1.9× 268 1.3× 105 0.8× 38 0.3× 32 1.3k
Alejandro C. Curino Argentina 20 618 0.7× 222 1.1× 144 0.7× 89 0.7× 84 0.7× 42 1.0k
Suning Chen China 20 949 1.0× 419 2.1× 169 0.8× 83 0.7× 57 0.5× 95 1.5k
Wendan Yu China 25 940 1.0× 315 1.6× 336 1.7× 69 0.5× 67 0.5× 50 1.5k
Mustapha Kandouz United States 25 979 1.0× 279 1.4× 305 1.5× 211 1.7× 249 2.0× 42 1.6k
S. Kulkarni United States 20 440 0.5× 180 0.9× 164 0.8× 75 0.6× 29 0.2× 41 1.3k
Meriç A. Altinoz Türkiye 21 532 0.6× 217 1.1× 139 0.7× 68 0.5× 112 0.9× 89 1.2k
Sarah M. Mense United States 16 918 1.0× 247 1.2× 176 0.9× 54 0.4× 227 1.8× 17 1.4k

Countries citing papers authored by Umesh T. Sankpal

Since Specialization
Citations

This map shows the geographic impact of Umesh T. Sankpal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Umesh T. Sankpal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Umesh T. Sankpal more than expected).

Fields of papers citing papers by Umesh T. Sankpal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Umesh T. Sankpal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Umesh T. Sankpal. The network helps show where Umesh T. Sankpal may publish in the future.

Co-authorship network of co-authors of Umesh T. Sankpal

This figure shows the co-authorship network connecting the top 25 collaborators of Umesh T. Sankpal. A scholar is included among the top collaborators of Umesh T. Sankpal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Umesh T. Sankpal. Umesh T. Sankpal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sankpal, Umesh T., et al.. (2023). Abstract 6255: Anti-proliferative effect of two copper complexes against medulloblastoma cells. Cancer Research. 83(7_Supplement). 6255–6255. 2 indexed citations
2.
Sankpal, Umesh T., Don Eslin, W. Paul Bowman, et al.. (2019). Clotam enhances anti-proliferative effect of vincristine in Ewing sarcoma cells. APOPTOSIS. 24(1-2). 21–32. 5 indexed citations
3.
Patel, Krishna, et al.. (2019). Impact of the Microbiome on the Immune System. Critical Reviews in Immunology. 39(5). 313–328. 49 indexed citations
4.
Sankpal, Umesh T., et al.. (2018). Novel Survivin Inhibitor for Suppressing Pancreatic Cancer Cells Growth via Downregulating Sp1 and Sp3 Transcription Factors. Cellular Physiology and Biochemistry. 51(4). 1894–1907. 23 indexed citations
5.
Bowman, W. Paul, et al.. (2018). Abstract 889: Metformin treatment inhibits proliferation and induces apoptosis in medulloblastoma cells. Cancer Research. 78(13_Supplement). 889–889. 1 indexed citations
6.
Sankpal, Umesh T., et al.. (2017). Abstract 10: A small molecule derivative effectively inhibits proliferation of pancreatic cancer cells by targeting Sp1 and survivin. Cancer Research. 77(13_Supplement). 10–10. 1 indexed citations
7.
Sankpal, Umesh T., et al.. (2017). Tolfenamic acid-induced alterations in genes and pathways in pancreatic cancer cells. Oncotarget. 8(9). 14593–14603. 9 indexed citations
8.
Basha, Riyaz, Umesh T. Sankpal, Ganji Purnachandra Nagaraju, et al.. (2016). Small molecule tolfenamic acid and dietary spice curcumin treatment enhances antiproliferative effect in pancreatic cancer cells via suppressing Sp1, disrupting NF-kB translocation to nucleus and cell cycle phase distribution. The Journal of Nutritional Biochemistry. 31. 77–87. 40 indexed citations
9.
Sankpal, Umesh T., et al.. (2016). Targeting specificity protein 1 transcription factor and survivin using tolfenamic acid for inhibiting Ewing sarcoma cell growth. Investigational New Drugs. 35(2). 158–165. 22 indexed citations
10.
Sankpal, Umesh T., Susan B. Ingersoll, Sarfraz Ahmad, et al.. (2016). Association of Sp1 and survivin in epithelial ovarian cancer: Sp1 inhibitor and cisplatin, a novel combination for inhibiting epithelial ovarian cancer cell proliferation. Tumor Biology. 37(10). 14259–14269. 24 indexed citations
11.
Sankpal, Umesh T., Susan B. Ingersoll, Mohammed Ibrahim Shukoor, et al.. (2013). Abstract 2159: Expression of Sp1 and survivin in ovarian cancer specimens: potential novel therapeutic targets in disease treatment.. Cancer Research. 73(8_Supplement). 2159–2159. 1 indexed citations
12.
Eslin, Don, Chris Lee, Umesh T. Sankpal, et al.. (2013). Anticancer activity of tolfenamic acid in medulloblastoma: a preclinical study. Tumor Biology. 34(5). 2781–2789. 21 indexed citations
13.
Sankpal, Umesh T., Chris M. Lee, Don Eslin, et al.. (2013). Cellular and Organismal Toxicity of the Anti-Cancer Small Molecule, Tolfenamic Acid: a Pre-Clinical Evaluation. Cellular Physiology and Biochemistry. 32(3). 675–686. 21 indexed citations
14.
Sankpal, Umesh T., Maen Abdelrahim, Chris M. Lee, et al.. (2012). Small molecule tolfenamic acid inhibits PC‐3 cell proliferation and invasion in vitro, and tumor growth in orthotopic mouse model for prostate cancer. The Prostate. 72(15). 1648–1658. 34 indexed citations
15.
Basha, Riyaz, Susan B. Ingersoll, Umesh T. Sankpal, et al.. (2011). Tolfenamic acid inhibits ovarian cancer cell growth and decreases the expression of c-Met and survivin through suppressing specificity protein transcription factors. Gynecologic Oncology. 122(1). 163–170. 48 indexed citations
16.
Eslin, Don, Umesh T. Sankpal, Chris Lee, et al.. (2011). Tolfenamic acid inhibits neuroblastoma cell proliferation and induces apoptosis: A novel therapeutic agent for neuroblastoma. Molecular Carcinogenesis. 52(5). 377–386. 27 indexed citations
17.
Maliakal, Pius, et al.. (2011). Relevance of Drug Metabolizing Enzyme Activity Modulation by Tea Polyphenols in the Inhibition of Esophageal Tumorigenesis. Medicinal Chemistry. 7(5). 480–487. 7 indexed citations
18.
Khaitan, Divya, Umesh T. Sankpal, Babette B. Weksler, et al.. (2009). Role of KCNMA1gene in breast cancer invasion and metastasis to brain. BMC Cancer. 9(1). 258–258. 103 indexed citations
19.
Ningaraj, Nagendra S., et al.. (2007). Targeted Brain Tumor Treatment-Current Perspectives. SHILAP Revista de lepidopterología. 2(1). 2 indexed citations
20.
Geiman, Theresa M., et al.. (2004). DNMT3B interacts with hSNF2H chromatin remodeling enzyme, HDACs 1 and 2, and components of the histone methylation system. Biochemical and Biophysical Research Communications. 318(2). 544–555. 87 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shoshana Paglin Breakdown of academic impact, for papers by Yingjie Li Breakdown of academic impact, for papers by Wei‐En Yang Breakdown of academic impact, for papers by Alejandro C. Curino Breakdown of academic impact, for papers by Suning Chen Breakdown of academic impact, for papers by Wendan Yu Breakdown of academic impact, for papers by Mustapha Kandouz Breakdown of academic impact, for papers by S. Kulkarni Breakdown of academic impact, for papers by Meriç A. Altinoz Breakdown of academic impact, for papers by Sarah M. Mense
Rankless by CCL
2026